One Team, One Goal: The Key to Better Patient Outcomes in Early Breast Cancer Management Authors: Fatima Cardoso, MD, FESMO, ESCO; Nadia Harbeck, MD, PhD; Shani Paluch, MBBS, MSc

https://www.medscape.org/viewarticle/1002593?sso=true&uac=148436CN&src=mkmcmr_driv_stan_mscpedu_251026-OUS-HONC-1002593-cta

Can PSMA-PET Improve Outcomes in Prostate Cancer? ++++ +++ ++

Imaging Can PSMA-PET Improve Outcomes in Prostate Cancer? https://www.medscape.com/viewarticle/can-psma-pet-improve-outcomes-prostate-cancer-2025a1000rd2?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 Prostate SBRT: How Low the Dose Can Go https://www.medscape.com/viewarticle/how-low-can-you-go-prostate-sbrt-trials-find-dose-trade-2025a1000rhc?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 PSMA-PET Volume Predicts Lu-PSMA Benefit https://www.medscape.com/viewarticle/psma-pet-tumor-volume-predicts-added-benefit-lu-psma-617-2025a1000nej?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 Can Contrast-Free MRI Replace Standard Scans? https://www.medscape.com/viewarticle/contrast-free-mri-optimal-test-pc-2025a1000nv9?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 Treatment and Risks Many With Mets Prostate Cancer Not Receiving PARP Inhibitors https://www.medscape.com/viewarticle/many-metastatic-prostate-cancer-not-receiving-parp-2025a1000que?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 Biomarker May Refine Hormone Therapy https://www.medscape.com/viewarticle/predictive-biomarker-guides-prostate-cancer-hormone-therapy-2025a1000qdo?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 Paternal Prostate Cancer Ups Early-Onset Risk in Sons https://www.medscape.com/viewarticle/paternal-prostate-cancer-diagnosis-linked-early-onset-risk-2025a1000opr?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 US Drug Spotlight Olaparib https://reference.medscape.com/drug/lynparza-olaparib-999934?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914 Enzalutamide https://reference.medscape.com/drug/xtandi-enzalutamide-999769?ecd=mkm_ret_251026_mscpmrk_onc_prostate-cancer_etid_etid7820914&uac=148436CN&impID=7820914

Transforming mental health in Europe +... ++ +...

Europe is facing a mental health crisis: 17% of people in the WHO European Region have a mental health condition, and one in three do not receive the treatment they need. Armed conflicts, economic uncertainty, and the climate crisis have intensified demand and exposed systemic weaknesses, building on the increased pressures created by the COVID-19 pandemic. Services remain underfunded, fragmented, and unequally distributed. This Series responds to the urgent need for action by synthesising evidence across four areas: the wellbeing of health-care workers, the mental health of children and young people, challenges in Central and Eastern Europe, and gaps in service coverage. The Series calls for bold investment, empowered workforces and community-based reform, to build resilient, equitable systems across Europe. https://www.thelancet.com/series-do/mental-health-europe?dgcid=hubspot_email_infocusalerts-psychiatry_feature_lanepemheurope25&utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz--WuAs3uKGgnhktthrsOb3U2R-MO3GVwG5KMn56q6PpXw4aEyZPGSSm_OzxYxIBbcG3rLnekc5fMvDG5KlOF6AGwFmS5w&_hsmi=386846770&utm_content=386532747&utm_source=hs_email Graham Thornicroft on transforming mental health in Europe October 06, 2025 • The Lancet Group https://thelanceteurope.buzzsprout.com/2517336/episodes/17932648-graham-thornicroft-on-transforming-mental-health-in-europe?utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz-86Kmq5RzFVao6LG4CWfNJwPhvLNe4_RImKOmaQwcY2NgcOXM3jcFbfUR9TnPjCnlIdpk--fYWyGwyuiryI5nSFGykv4w&_hsmi=386846770&utm_content=386532747&utm_source=hs_email Weight trajectories and access to weight management services in individuals with severe mental illness in the UK: a population-based, matched cohort study https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00212-3/fulltext?dgcid=hubspot_email_infocusalerts-psychiatry_feature&utm_campaign=infocusalerts-psychiatry&utm_medium=email&_hsenc=p2ANqtz-8x0KT08xm2f0NLGKFMYMuJaPUz3cYXKUgXyYNZPcNQ0ccaFknQ3ihbEhApKTeTPE7lTsNKIvgXlw6LlTogMVbtKy6fZQ&_hsmi=386846770&utm_content=386532747&utm_source=hs_email Editorial p723 New perspectives on prevention The Lancet Psychiatry https://www.thelancet.com/journals/lanpsy/issue/vol12no10/PIIS2215-0366(25)X0010-9

Advancing Clinical Excellence Pathways in Rare Disease

Advancing Clinical Excellence Pathways in Rare Disease Rare diseases affect approximately 300 million + patients worldwide. Yet, the journey to the right diagnosis takes an average 6 to 8 years with visits to multiple specialists and misdiagnoses along the way. https://www.medscape.org/advances/rare-disease-2025a100013m

Tumor Board Would you choose surgery, radiation, or immunotherapy for aggressive cutaneous malignancies? Authors: David Miller, MD, PhD; Vishal A. Patel, MD; Kevin Emerick, MD; Vernon Sondak, MD; Mehran Yusuf, MD

https://www.medscape.org/viewarticle/tumor-board-2025a1000sfn

Debating New IBD Treatments: Ready, Set, Go! Hear from 2 experts as they discuss how they select treatments for inflammatory bowel disease (IBD). Authors: Russell D. Cohen, MD, AGAF; Anita Afzali, MD, MPH, MHCM, FACG, AGAF

https://www.medscape.org/viewarticle/debating-new-ibd-treatments-ready-set-go-2025a1000srz

Immunotherapy - A Revolutionary Approach for Difficult-to-Treat Cancers: Comprehensive Learning Center

https://www.medscape.org/sites/advances/cancer-immunotherapy